Description
About this compound
GLP-3 RT is the research designation for LY3437943. It acts on three receptors at once: GLP-1, GIP and glucagon. Research has examined metabolism, energy use and blood glucose endpoints in study models. Most similar compounds bind only two receptors; the third target is the distinguishing feature.
Triple GLP-1/GIP/glucagon receptor agonist peptide (LY3437943)






Reviews
There are no reviews yet.